is an uncommon tumor that occurs mostly in women whereas men are rarely diagnosed with this disease but that doesn’t rule their possibility of being at risk. There are different kinds of urethral cancer that instigate in cells that line the urethra. These  are named for the types of cells that turn out to be cancerous:

  • Squamous cell carcinoma: It builds up in plane, encrusted surface cells and is the most ordinary kind of urethral cancer.
  • Transitional cell carcinoma: It develops in surface cells of the urethra
  • Adenocarcinoma: It builds up in glands positioned near the urethra

Dissimilar kinds of urethral tumor build up in diverse kinds of cells and in different portions of the urethra.

Analysis of urethral cancer is made by physical tests and biopsy. The urethra and the bladder are methodically examined by means of a slender, lighted tube that is inserted into the urethra. If a doubtful abrasion is sited, a tiny piece of tissue is detached surgically and examined under a microscope for tumor cells. If the biopsy results are positive, imaging tests are done to stage the tumor. These tests include:

  • X-ray
  • Ultrasound
  • Computed tomography (CT scan)
  • Magnetic resonance imaging (MRI scan)

Restorative management (healing options) depends upon the stage and location of the lesion. Because of the uncommonness of this pathology and short of statistical study on the data, no consensus has been reached on cure modalities. Surgical treatment alternatives rely on the phase and site of the cancer. Early urethral cancer is treated using:

  • Fulguration (obliteration of tumor cells by means of high-frequency electric current)
  • Laser therapy (annihilation of tumor cells by means of a thin beam of intense light)

Procedures performed for highly developed cases take in the following:

  • elimination of the bladder and urethra
  • elimination of part of the penis
  • elimination of the penis, urethra, and penile root
  • taking away the bladder and prostate
  • removal of cancerous lymph nodes
  • taking away the bladder, urethra, and vagina

Radiation may be used together with surgical procedures in highly developed urethral cancer, or as primary treatment for premature urethral cancer that is noninvasive. Five-year survival rates for noninvasive urethral tumor treated surgically or with radiation are around 60%. Reappearance rates for persistent urethral cancer treated surgically, by chemotherapy, and radiation all combined together are more than 50%. Early identification and treatment offers the best chance for cure.